HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Wellness)

Set Alert for Business {Wellness}

Stada Looks To Take Slice Of Growing Probiotics Market With Launch Of Probielle In Germany

Stada Arzneimittel moves into the German probiotics market with four new products under its Probielle brand.

Wellness Dietary Supplements Launches

Horlicks Brings Unilever 'Transformative' Nutritional Deal, Market Challenges

Firm's Hindustan Unilever division will merge with s GSK Consumer Healthcare India which has had total sales around €550m so far in 2018, primarily through the Horlicks and Boost brands and with nearly 90% of the revenues in India. Also will acquire 82% stake in GSK Bangladesh and other GSK commercial operations and assets outside India, paying €3.3bn in combination of cash and shares in Hindustan Unilever.

Dietary Supplements Commercial M & A

FDA Review Of Dietary Ingredients For Pharmacy Compounding Could Open Door To Change DSHEA

FDA could look for Congress to amend DSHEA as it creates a “deep” administrative record on dietary ingredients placed on a list of substances no longer allowed for use by compounding pharmacies, says integrative medicine attorney Alan Dumoff. Pharmacy organizations are writing a citizen petition to ward off what they fear will be an excuse to step-up regulation of supplement manufacturing and marketing.

Regulation Dietary Supplements Advisory Committees

Deals

Set Alert for Deals {Wellness}

Latest From Wellness & Deals

GSK Begins ‘New Chapter’ in India As It Offloads Nutrition Brands

GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.

India Business Strategies

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

Dietary Supplements Sales & Earnings

Podcast: How GSK's £1bn OTC Brand Sale Is Reshaping The Global Market

As GSK continues to sell off OTC assets in the wake of its merger with Pfizer, HBW Insight Editors Tom Gallen and David Ridley discuss how this torrent of M&A activity is shaking up the global consumer healthcare market. 

Market Intelligence Business Strategies
See All

Strategy

Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Coronavirus COVID-19 Market Intelligence

GSK Begins ‘New Chapter’ in India As It Offloads Nutrition Brands

GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.

India Business Strategies

Coronavirus Pandemic Disrupting Dietary Ingredient Supply Chain? USDA Wants To Know

'We've got be sure that companies can continue to get ingredients for their products," says CRN CEO Steve Mister, Concern supplies from India, which is a week into a a three-week nationwide lockdown, and other potential supply chain problems were noted by CRN members in a survey it conducted to help USDA gauge global food and nutrition ingredient supply chains during the pandemic.

Coronavirus COVID-19 Distribution
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

Dietary Supplements Sales & Earnings

RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

Business Strategies Sales & Earnings

Perrigo's Infant Formula Already A Key Sales Driver, And Nutrition Sector Takes Larger Role Ahead

OTC private label giant said gaining another grocery chain as an infant formula customer was a key sales driver in the 2019 Q4, with nutrition sales up 21% to account for 17% of Americas consumer health sales growth. The firm plans to re-enter the broader VMS space, but infant formula helped its global consumer health net sales reach $1.1bn in the October-December period.

Sales & Earnings OTC Drugs
See All

Litigation

Set Alert for Legal Issues

Latest From Wellness & Legal Issues

Italy’s Dompé Taking Legal Action Over COVID-19 Fake News

Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.

Dietary Supplements Italy

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.

United States Legal Issues

Fewer Arrows Left In Quincy's Quiver To Defend Against FTC's Prevagen Supplement Complaint

"There is no need to litigate the same issue again," says District Judge Louis Stanton in granting most of the joint motions by FTC and New York attorney general to strike Quincy Bioscience's proposed defenses. The judge denied other motions, including whether NY state laws are applicable, saying a trial is needed to weigh the evidence.

Dietary Supplements Ad Complaints
See All
UsernamePublicRestriction

Register